Takaaki Suzuki

Takaaki Suzuki

Auto-generated profile, based on publicly available information

Takaaki Suzuki

Division of Pharmacy, Chiba University Hospital, Chiba, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
SYShingo Yamazaki
Shingo Yamazaki
TSTakaaki Suzuki
Takaaki Suzuki
MSMisa Sayama
Misa Sayama
TNTaka-Aki Nakada
Taka-Aki Nakada
HIHidetoshi Igari
Hidetoshi Igari
IIItsuko Ishii
Itsuko Ishii

2 September 2019 in Journal of Pharmaceutical Health Care and Sciences
Verified
Journal Article
Open access
PDF file
SASayaka Arai
Sayaka Arai
TITakahiro Ishikawa
Takahiro Ishikawa
HKHisaya Kato
Hisaya Kato
MKMasaya Koshizaka
Masaya Koshizaka
YMYoshio Maezawa
Yoshio Maezawa
IIItsuko Ishii
Itsuko Ishii
There is a lack of evidence that multidrug use triggers adverse events. Therefore, the main purpose of this study was to clarify the relationship between the total number of drugs and number of high-risk prescriptions administered to Japanese elderly patients. Using hospital electronic medical records (EMR), we evaluated the prescriptions of outpatients aged 65 years or older. We defined prescriptions of potentially inappropriate medications (PIMs) and overlapping prescription of drugs with the same mechanism of action (DSAs) as high-risk prescriptions. We analyzed the relationship among total number of drugs and high-risk prescriptions. In addition, we performed a secondary research to determine whether the hospitalization rate and concomitant medication contents differ depending on the high-risk prescriptions. Data for 13,630 outpatients were analyzed. A significant positive correlation between the numbers of total drugs and PIMs was found. The prescription frequency of individual PIMs rose as the total number of prescription drugs increased. The odds ratio (OR) of overlapping DSAs was significantly higher in patients using 5 or more drugs. In addition, there were significantly more prescriptions of laxatives among patients with overlapping prescriptions of anticholinergic drugs. The use of almost all PIMs was not an independent risk factor for hospitalization; instead, the number of PIMs was an independent risk factor for hospitalization [OR 1.18 (95% CI, 1.12–1.26)]. The number of PIMs and overlapping DSAs were high in patients receiving multidrug treatment. To avoid adverse events and hospitalization, it might be useful to review prescriptions and consider the number of PIMs and overlapping DSAs.

10 December 2004 in Color Research & Application
Verified
Journal Article
Open access
PDF file
TST. Suzuki
T. Suzuki
QYQ. Yi
Q. Yi
SSS. Sakuragawa
S. Sakuragawa
HTH. Tamura
H. Tamura
KOK. Okajima
K. Okajima
We measured response time, the number of nonresponses, response error, and subjective visibility evaluation for color Landolt‐Cs with a gray color background presented on a CRT display to young and old adults (mean ages: 22.3 and 65.9 years, respectively) and to the same young adults wearing glasses with filters simulating an aging human crystalline lens. Comparing the results of elderly and young subjects without the filter, the results of the elderly subjects showed a longer response time, higher nonresponse ratio, slower response speed, and lower visibility, particularly for gray and blue stimuli. Conversely, the results for the young subjects who were fitted with the filters showed tendencies similar to those of the elderly subjects. These results indicate that the yellowing of the human lens strongly influences the visibility of color targets in the elderly and that wearing the filters enables young adults to simulate the visibility of the elderly. It suggests that the simulated filter as well as the aging human lens modifies the effective luminance, effective luminance contrast, and color difference between the color target and the background on the retina. Moreover, the relationship between the subjective evaluation and the response speed changes remarkably with age, regardless of the filters, suggesting that not only the subjective evaluation but also the evaluation of the performance, such as response speed, is important in estimating visibility and controllability in the elderly. The filter used in the present study will be an effective tool for the young to evaluate the visibility of elderly adults in terms of both response speed and subjective evaluation of visibility. © 2004 Wiley Periodicals, Inc. Col Res Appl, 30, 5–12, 2005; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/col.20071

1 April 2022 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
YNYoko Niibe
Yoko Niibe
TSTatsuya Suzuki
Tatsuya Suzuki
SYShingo Yamazaki
Shingo Yamazaki
MUMasashi Uchida
Masashi Uchida
TSTakaaki Suzuki
Takaaki Suzuki
IIItsuko Ishii
Itsuko Ishii

8 August 2023 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
KAKenichi Arai
Kenichi Arai
KYKohei Yamamoto
Kohei Yamamoto
TSTakaaki Suzuki
Takaaki Suzuki
YSYuki Shiko
Yuki Shiko
YKYohei Kawasaki
Yohei Kawasaki
IIItuko Ishii
Ituko Ishii

15 March 2022 in Oncology Letters
Verified
Journal Article
Open access
PDF file
CIChiaki Imai
Chiaki Imai
HSHiromi Saeki
Hiromi Saeki
KYKohei Yamamoto
Kohei Yamamoto
AIAyano Ichikawa
Ayano Ichikawa
MAMakoto Arai
Makoto Arai
IIItsuko Ishii
Itsuko Ishii
Clinical trials have not fully demonstrated the efficacy and safety of radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer (LA‑SCCHN) in patients with cisplatin‑ineligible renal dysfunction. Patients who received radiotherapy plus cetuximab for LA‑SCCHN at Chiba University Hospital (Chiba, Japan) between July 2013 and October 2018 were retrospectively reviewed. Background characteristics and locoregional control and overall survival rates were compared between patients with and without renal dysfunction. Survival was examined using Kaplan‑Meier analysis and an adjusted Cox proportional hazards model. Kaplan‑Meier analysis demonstrated that overall survival was shorter in patients with creatinine clearance of <45 ml/min (P=0.041; log‑rank test). However, there was no difference in the locoregional control rate (P=0.477; log‑rank test). Adjusted Cox analysis revealed that the risk of death was increased by 2.52‑fold (hazard ratio, 2.52; 95% confidence interval, 1.01‑6.30; P=0.048) if creatinine clearance was <45 ml/min. Moderate to severe renal dysfunction did not affect the locoregional control rate in patients with LA‑SCCHN treated with radiotherapy plus cetuximab but was an adverse prognostic factor.